tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

RMD Stock Latest News

Orthofix appoints Stephanie Walsh as chief human resources officer
The FlyOrthofix appoints Stephanie Walsh as chief human resources officer
9d ago
RMD
OFIX
GLP-1 concerns clobbered ResMed stock, time to buy, Barron’s
PremiumThe Fly
GLP-1 concerns clobbered ResMed stock, time to buy, Barron’s
11d ago
LLY
RMD
ResMed price target raised to $230 from $225 at BofA
PremiumThe Fly
ResMed price target raised to $230 from $225 at BofA
13d ago
RMD
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
PremiumPress Releases
ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
22d ago
RMD
Needham medtech & diagnostics analyst holds analyst/industry conference call
PremiumThe Fly
Needham medtech & diagnostics analyst holds analyst/industry conference call
23d ago
RMD
INSP
Disney, MicroStrategy initiated: Wall Street’s top analyst calls
PremiumThe FlyDisney, MicroStrategy initiated: Wall Street’s top analyst calls
1M ago
DV
DIS
Oppenheimer downgrades ResMed on sleep apnea GLP-1 risk
PremiumThe Fly
Oppenheimer downgrades ResMed on sleep apnea GLP-1 risk
1M ago
RMD
ResMed downgraded to Perform from Outperform at Oppenheimer
PremiumThe Fly
ResMed downgraded to Perform from Outperform at Oppenheimer
1M ago
RMD
ResMed falls -11.3%
PremiumThe Fly
ResMed falls -11.3%
1M ago
RMD
ResMed falls -10.7%
PremiumThe Fly
ResMed falls -10.7%
1M ago
RMD
ResMed falls -7.5%
PremiumThe Fly
ResMed falls -7.5%
1M ago
RMD
Planet Fitness upgraded, Comcast downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Planet Fitness upgraded, Comcast downgraded: Wall Street’s top analyst calls
1M ago
SQ
CNK
ResMed downgraded to Neutral from Buy at Citi
PremiumThe FlyResMed downgraded to Neutral from Buy at Citi
1M ago
RMD
Australian Stocks: ResMed Shares Tumble on Rival’s Weight-Loss Drug Results
PremiumGlobal Markets
Australian Stocks: ResMed Shares Tumble on Rival’s Weight-Loss Drug Results
1M ago
LLY
RMD
ResMed shares slip after Eli Lilly reports sleep apnea study data
PremiumThe Fly
ResMed shares slip after Eli Lilly reports sleep apnea study data
1M ago
LLY
RMD
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
PremiumPress Releases
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
2M ago
RMD
ResMed announces PAP therapy reduces hospitalizations by 31%, ER visits by 23%
PremiumThe Fly
ResMed announces PAP therapy reduces hospitalizations by 31%, ER visits by 23%
2M ago
RMD
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
PremiumPress Releases
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
2M ago
RMD
ResMed issues new research, insights into effectiveness of PAP therapy
PremiumThe Fly
ResMed issues new research, insights into effectiveness of PAP therapy
2M ago
RMD
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
PremiumPress ReleasesATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
2M ago
RMD
ResMed’s MatrixCar partners with Health Gorilla
PremiumThe Fly
ResMed’s MatrixCar partners with Health Gorilla
2M ago
RMD
ResMed price target raised to $195 from $180 at UBS
PremiumThe Fly
ResMed price target raised to $195 from $180 at UBS
3M ago
RMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >